Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Receptor protein tyrosine kinases, like STYK1, play important roles in diverse cellular and developmental processes, such as cell proliferation, differentiation, and survival (Liu et al., 2004 [PubMed 15150103]).[supplied by OMIM, Mar 2008].. Additionally we are shipping STYK1 Proteins (6) and STYK1 Kits (2) and many more products for this protein.
Showing 10 out of 88 products:
Chicken Polyclonal STYK1 Primary Antibody for WB - ABIN2782971
Ye, Ji, Huang, Cheng, Tang, Xu, Zeng, Dai, Wu, Gu, Xie, Mao: Isolation and characterization of a human putative receptor protein kinase cDNA STYK1. in Molecular biology reports 2003
Human Monoclonal STYK1 Primary Antibody for IHC, ELISA - ABIN969425
Pan, Liu, Yang, Zhou, Wu: Research on the Diversity of PLA(2) Gene from Agkistrodon halys Pallas. in Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica 2002
High STYK1 expression is associated with intrahepatic cholangiocarcinoma.
increased STYK1 protein expression correlates with disease progression and metastasis and may serve as a predictor of poor survival in CRC (show CALR Antibodies).
The data indicates that both P203 and V395 residues on NOK are important for NOK mediated mitogenic signaling.
NOK expression increased in renal cell carcinoma (show MOK Antibodies) and was significantly correlated with TNM (show ODZ1 Antibodies) stage, Fuhrman grade, poor overall survival, poor disease-free survival, metastasis, and proliferation.
STYK1/NOK is dramatically upregulated in colorectal cancer tissues and could be used as a tumor marker. Furthermore, the high expression of STYK1/NOK is significantly associated with tumor size.
These results suggest that STYK1 is a novel drug resistance factor and could be a predictor of the therapeutic response in acute leukemia.
Our results indicate that NOK expression is of clinical significance and can serve as a prognostic biomarker in non-small cell lung cancer.
SuRTK106/NOK/STYK1 was first identified, classified and shown to have predicted pseudokinase domain.
The expression levels of NOK, p-Akt (show AKT1 Antibodies)(Thr308) and p-GSK-3beta (show GSK3b Antibodies)(Ser9) were positively correlated in cancerous and non-cancerous breast cell lines.
Taken together, NOK has a strong tendency towards forming aggregates, which may have physiological implications and provide the first evidence that this novel receptor kinase is colocalised with EGFR (show EGFR Antibodies) in endosomes to participate in a post-internalisation step of EGFR (show EGFR Antibodies).
Point mutations at either Y327 or Y356 dramatically blocked cellular transformation by NOK as examined by colony formation and cellular DNA synthesis.
Receptor protein tyrosine kinases, like STYK1, play important roles in diverse cellular and developmental processes, such as cell proliferation, differentiation, and survival (Liu et al., 2004
, serine/threonine/tyrosine kinase 1
, tyrosine-protein kinase STYK1-like
, novel oncogene with kinase domain
, protein PK-unique
, tyrosine-protein kinase STYK1
, NOK kinase